PLSH
PANACEA LIFE SCIENCES HOLDINGS, INC.
$0.0290
+2.87%
No data for this timeframe.
Vol
Exchange OTC·Sector Medicinal Chemicals & Botanical Products·Inc. NV·CIK 0001552189·Prev Close $0.0282
Recent Activity
May 12, 2026
earnings_calendar
PLSH Q1 2026 Earnings Scheduled — 2026-05-12
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 12, 2026
earnings_calendar
PLSH Q1 2026 Earnings Scheduled — 2026-05-12
Mar 30, 2026
earnings_calendar
PLSH Q4 2025 Earnings Scheduled — 2026-03-30
Feb 20, 2026
Clinical Trial
a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients
Phase Phase 3 — COMPLETED